SARS-CoV Nucleocapsid protein (Recombinant) (C-His) (STJP001288)
SPECIFICATIONS
HostE.coli
ConjugationUnconjugated
ImmunogenRecombinant SARS-CoV Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala422) of sars-cov Nucleocapsid (Accession #NP_828858.1) fused with a 6ΓHis tag at the C-terminus.
General Information
| Short Description | Recombinant-SARS-CoV Nucleocapsid-C-His protein was developed in e.coli using the region Met1-Ala422. For use in research applications. |
| Host | E.coli |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Formulation | Supplied as a 0.22 Mu m filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 20% Glycerol, pH 8.0. |
| Storage Instruction | Store at-20Β°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | Please contact us for more information. |
Target Information
| Immunogen | Recombinant SARS-CoV Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala422) of sars-cov Nucleocapsid (Accession #NP_828858.1) fused with a 6ΓHis tag at the C-terminus. |
| Immunogen Region | Met1-Ala422 |
| Immunogen Sequence | MSDNGPQSNQRSAPRITFGG PTDSTDNNQNGGRNGARPKQ RRPQGLPNNTASWFTALTQH GKEELRFPRGQGVPINTNSG PDDQIGYYRRATRRVRGGDG KMKELSPRWYFYYLGTGPEA SLPYGANKEGIVWVATEGAL NTPKDHIGTRNPNNNAATVL QLPQGTTLPKGFYAEGSRGG SQASSRSSSRSRGNSRNSTP GSSRGNSPARMASGGGETAL ALLLLDRLNQLESKVSGKG |
Additional Info
| Background | Recombinant SARS-CoV Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala422) of sars-cov Nucleocapsid (Accession #NP_828858.1) fused with a 6ΓHis tag at the C-terminus. |
Information sourced from Uniprot.org